Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer McEachron

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Gynecologic Oncology Reports|October 31, 2025
Early introduction of trastuzumab deruxtecan (T-DXd) in HER2 expressing rare gynecologic malignancies - How early is too early?Jennifer McEachron, Jamie N Bakkum-Gamez
Gynecologic Oncology Reports|July 17, 2020
Cutaneous metastasis of PD-L1 positive ovarian carcinomaVictoria Hastings, Jennifer McEachron, Marguax J Kanis
Gynecologic Oncology Reports|June 29, 2026
Master Class: Writing a Case Report - Reflections on a Recently Published Case ReportJennifer McEachron, Susan C Modesitt, Jamie N Bakkum-Gamez
Gynecologic Oncology Reports|February 2, 2026
Rare case of primary HPV negative vaginal cancer presenting in a young woman with normal cervixErin Carter, Teri Nguyen-Guo, Paulina Guta, et al.
Gynecologic Oncology Reports|October 29, 2019
Breast metastases: A rare manifestation of advanced uterine serous carcinomaJennifer McEachron, Rachel Mendoza, Yi-Chun Lee, et al.
Oncology Letters|January 22, 2024
Predicting long‑term survival following involved site radiotherapy for oligometastasesJohnny Kao, Patricia Eckardt, Jennifer Mceachron, et al.
Frontiers in Medicine|July 2, 2025
Case Report: Serous borderline ovarian tumor and extensive abdominopelvic endometriosis mimicking advanced epithelial ovarian cancer in a postmenopausal patientKatherine Livatova, Anthony D Nguyen, John Pizzuti, et al.
Gynecologic Oncology Reports|January 13, 2022
Evaluation of the incidence and clinical significance of WT-1 expression in uterine serous carcinomaJennifer McEachron, Agha Wajdan Baqir, Nancy Zhou, et al.
Journal of Gynecologic Oncology|October 20, 2020
Evaluation of the optimal sequence of adjuvant chemotherapy and radiation therapy in the treatment of advanced endometrial cancerJennifer McEachron, Nancy Zhou, Christina Spencer, et al.
Cancer Treatment and Research Communications|September 12, 2022
Optimal cytoreduction followed by chemoradiation in stage IVB uterine serous carcinomaJennifer McEachron, Nancy Zhou, Victoria Hastings, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Gynecologic Oncology Reports|October 31, 2025
Early introduction of trastuzumab deruxtecan (T-DXd) in HER2 expressing rare gynecologic malignancies - How early is too early?Jennifer McEachron, Jamie N Bakkum-Gamez
Gynecologic Oncology Reports|July 17, 2020
Cutaneous metastasis of PD-L1 positive ovarian carcinomaVictoria Hastings, Jennifer McEachron, Marguax J Kanis
Gynecologic Oncology Reports|June 29, 2026
Master Class: Writing a Case Report - Reflections on a Recently Published Case ReportJennifer McEachron, Susan C Modesitt, Jamie N Bakkum-Gamez
Gynecologic Oncology Reports|February 2, 2026
Rare case of primary HPV negative vaginal cancer presenting in a young woman with normal cervixErin Carter, Teri Nguyen-Guo, Paulina Guta, et al.
Gynecologic Oncology Reports|October 29, 2019
Breast metastases: A rare manifestation of advanced uterine serous carcinomaJennifer McEachron, Rachel Mendoza, Yi-Chun Lee, et al.
Oncology Letters|January 22, 2024
Predicting long‑term survival following involved site radiotherapy for oligometastasesJohnny Kao, Patricia Eckardt, Jennifer Mceachron, et al.
Frontiers in Medicine|July 2, 2025
Case Report: Serous borderline ovarian tumor and extensive abdominopelvic endometriosis mimicking advanced epithelial ovarian cancer in a postmenopausal patientKatherine Livatova, Anthony D Nguyen, John Pizzuti, et al.
Gynecologic Oncology Reports|January 13, 2022
Evaluation of the incidence and clinical significance of WT-1 expression in uterine serous carcinomaJennifer McEachron, Agha Wajdan Baqir, Nancy Zhou, et al.
Journal of Gynecologic Oncology|October 20, 2020
Evaluation of the optimal sequence of adjuvant chemotherapy and radiation therapy in the treatment of advanced endometrial cancerJennifer McEachron, Nancy Zhou, Christina Spencer, et al.
Cancer Treatment and Research Communications|September 12, 2022
Optimal cytoreduction followed by chemoradiation in stage IVB uterine serous carcinomaJennifer McEachron, Nancy Zhou, Victoria Hastings, et al.
Pageof 2